Insulinoma: all 62 studies
Page 1 of 1. Open to participants first (12), then studies with results posted, then the rest; newest registration first within each.
- Comparison of [68Ga]Ga-HBED-CC-PEG6-Exendin-4 and [68Ga]Ga-HBED-CC-Exendin-4 PET/CT for Insulinoma LocalizationRecruitingNCT07808879Not applicable
- Safety and Efficacy of EUS-RFA in Pancreatic InsulinomaRecruitingNCT07585032
- Endoscopic Ultrasound-guided Radiofrequency Ablation for Upper Gastrointestinal Tract LesionsRecruitingNCT07272187
- Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a TumorAvailableNCT07262970
- A Phase 3 Study of Ersodetug in Patients With Tumor HyperinsulinismRecruitingNCT06881992Phase 3
- Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related DiseaseRecruitingNCT06725693
- A Multi-center Study to Evaluate the Efficacy and Safety of Pancreatic Duct Stents Placement Before the Enucleation of Insulinoma Located in the Head and Neck of the Pancreas Near the Main Pancreatic DuctRecruitingNCT05523778Not applicable
- Utility of 18FDOPA PET/MRI for Focal HyperinsulinismRecruitingNCT05088798Phase 2
- The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting InsulinomaRecruitingNCT04979611Phase 1
- Fluorodopa F 18 in Congenital Hyperinsulinism and InsulinomaRecruitingNCT02021604Phase 1
- 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic HypoglycemiaAvailableNCT01916148
- Diagnosing and Treating Low Blood Sugar LevelsRecruitingNCT00001276
- Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney CancerTerminatedNCT02273752Phase 2Results posted
- Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine TumorsCompletedNCT02259725Phase 2Results posted
- Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With SurgeryTerminatedNCT02031536Phase 2Results posted
- Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine TumorsCompletedNCT01824875Phase 2Results posted
- Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine TumorsCompletedNCT01525082Phase 2Results posted
- Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine TherapyTerminatedNCT01056601Phase 2Results posted
- Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine TumorsTerminatedNCT00730483Not applicableResults posted
- Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainCompletedNCT00538850Phase 3Results posted
- Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine CancerCompletedNCT00454363Phase 2Results posted
- AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine TumorsCompletedNCT00427349Phase 2Results posted
- Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine TumorsTerminatedNCT00227617Phase 2/3Results posted
- Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine TumorsCompletedNCT00131911Phase 2Results posted
- Clinical Study of 18F-Exendin-4 in InsulinomaCompletedNCT07340437
- EUS-RFA Versus Surgery for Pancreatic Insulinoma (ERASIN-RCT)Active, not recruitingNCT05735912Not applicable
- [68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma PatientsStatus unknownNCT05034783Early Phase 1
- 177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETsWithdrawnNCT04915144Phase 2
- Blinded Resection in Case of the Pancreatic InsulinomaCompletedNCT04741152
- CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive HypoglycaemiaTerminatedNCT04452396Not applicable
- Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of InsulinomaStatus unknownNCT04185350Early Phase 1
- Application of Raw Corn Starch on Patients With InsulinomaStatus unknownNCT03930368Not applicable
- DOTATOC PET/CT for Imaging NET PatientsActive, not recruitingNCT03583528
- 68Ga-NODAGA-exendin-4 PET/CT for Diagnostic Imaging in AHHCompletedNCT03189953Phase 1/2
- Laser Tissue Welding - Distal Pancreatectomy Sealing StudyCompletedNCT03147768Phase 1
- Pasireotide in Hyperinsulinemic HypoglycemiaWithdrawnNCT03053284Phase 2
- Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine TumorWithdrawnNCT02831179Phase 1
- 68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of NesidioblastosisStatus unknownNCT02560376Early Phase 1
- 18F-FDOPA PET in Neuroendocrine TumoursNo longer availableNCT02431715
- EUS-guided Ethanol Ablation of an InsulinomaStatus unknownNCT02121366Not applicable
- Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine TumorsWithdrawnNCT02108782Phase 2
- Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine CarcinomaCompletedNCT01204476Phase 1
- Whole Body 111In-exendin-4 Imaging Study in Insulinoma PatientsCompletedNCT00937079
- Everolimus and Vatalanib in Treating Patients With Advanced Solid TumorsCompletedNCT00655655Phase 1
- Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine TumorsCompletedNCT00602082Phase 2
- Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine TumorsTerminatedNCT00466856Phase 2
- Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine TumorsStatus unknownNCT00454376
- Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By SurgeryCompletedNCT00416767Phase 2
- Cinacalcet to Treat Familial Primary HyperparathyroidismCompletedNCT00325104Phase 3
- Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine TumorsWithdrawnNCT00227773Phase 2
- Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver CancerCompletedNCT00096083Phase 2
- Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine TumorsTerminatedNCT00084461Phase 2
- Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine TumorsCompletedNCT00075439Phase 2
- Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid TumorsCompletedNCT00049023Phase 1
- Thalidomide in Treating Patients With Metastatic Neuroendocrine TumorsCompletedNCT00027638Phase 2
- PS-341 in Treating Patients With Metastatic Neuroendocrine TumorsCompletedNCT00017199Phase 2
- Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerCompletedNCT00006368Phase 1
- Laparoscopy to Remove Pancreatic Tumors (Insulinomas)CompletedNCT00005910Not applicable
- Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the PeritoneumCompletedNCT00005860Phase 1
- Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerCompletedNCT00005842Phase 1
- Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
- Indium In 111 Pentetreotide in Treating Patients With Refractory CancerTerminatedNCT00002947Phase 1